The value of c-reactive protein to albumin ratio in predicting long term mortality among hfref patients with implantable cardiac defibrillators

23 April 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Goksel Cinier

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul (Turkiye)

286 More presentations in this session

Presentation thumbnail

Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene

Doctor T. Mikhalieva (Kyiv, UA)

Abstract Slides

Presentation thumbnail

Atrial fibrillation substrate mapping with decrement evoked potential mapping.

Doctor O. Salvador (Parla, ES)

Abstract Slides

Presentation thumbnail

Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation

Miss R. Adelino Recasens (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.

Doctor R. SERBAN (Targu Mures, RO)

Abstract Slides

Presentation thumbnail

Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation

Doctor C. Sohns (Bad Oeynhausen, DE)

Abstract Slides

Access the full session

Session thumbnail

ePoster session

The Event

EHRA 2021

23 April - 25 April 2021

You may be interested in

Congress Presentation

Implantable cardioverter-defibrillator

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Session

Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources